☰

Alexander D. Boiko - Publications

Affiliations: 
Molecular Biology and Biochemistry University of California, Irvine, Irvine, CA 
 2006-2012 Stanford University School of Medicine, Palo Alto, CA, United States 
Area:
Tumor Initiating Cells, Melanoma Immunotherapy, Tumor Evolution and Heterogeneity, Signal transduction in normal and cancer stem cell development
Website:
https://www.faculty.uci.edu/profile.cfm?faculty_id=5951
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Han A, Li C, Zahed T, Wong M, Smith I, Hoedel K, Green D, Boiko AD. Calreticulin is a Critical Cell Survival Factor in Malignant Neoplasms. Plos Biology. 17: e3000402. PMID 31568485 DOI: 10.1371/Journal.Pbio.3000402  0.457
2019 Filipp FV, Li C, Boiko AD. CD271 is a molecular switch with divergent roles in melanoma and melanocyte development. Scientific Reports. 9: 7696. PMID 31118427 DOI: 10.1038/S41598-019-42773-Y  0.511
2019 Li C, Nguyen V, Clark KN, Zahed T, Sharkas S, Filipp FV, Boiko AD. Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signaling. Proceedings of the National Academy of Sciences of the United States of America. PMID 30792348 DOI: 10.1073/Pnas.1813802116  0.476
2016 Ngo M, Han A, Lakatos A, Sahoo D, Hachey SJ, Weiskopf K, Beck AH, Weissman IL, Boiko AD. Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts. Cell Reports. PMID 27477289 DOI: 10.1016/J.Celrep.2016.07.004  0.576
2016 Dimov IK, Boiko AD. Profiling Melanoma Heterogeneity Using Microwell RNA Cytometry. Methods in Molecular Biology (Clifton, N.J.). PMID 27083169 DOI: 10.1007/7651_2016_351  0.385
2016 Hachey SJ, Boiko AD. Therapeutic implications of melanoma heterogeneity. Experimental Dermatology. 25: 497-500. PMID 27060971 DOI: 10.1111/Exd.13002  0.445
2013 Boiko AD. Isolation of melanoma tumor-initiating cells from surgical tissues. Methods in Molecular Biology (Clifton, N.J.). 961: 253-9. PMID 23325649 DOI: 10.1007/978-1-62703-227-8_16  0.383
2011 Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK, Krieg A, Bedogni B, LaGory E, Weissman IL, Broome-Powell M, Giaccia AJ. VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration. Proceedings of the National Academy of Sciences of the United States of America. 108: 1931-6. PMID 21233420 DOI: 10.1073/Pnas.1011777108  0.602
2011 Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK, Krieg A, Bedogni B, LaGory E, Weissman IL, Broome-Powell M, Giaccia AJ. Abstract LB-357: HIF-dependent over-expression of CUB domain-containing protein 1 stimulates migration in clear cell renal cell carcinoma Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-357  0.483
2011 Boiko AD, Razorenova OV, Van De Rijn M, Swetter SM, Johnson DL, Ly DP, Butler PD, Yang GP, Joshua B, Kaplan MJ, Longaker MT, Weissman IL. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 (Nature (2010) 466, (133-137)) Nature. 470: 424. DOI: 10.1038/nature09759  0.435
2010 Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, Butler PD, Yang GP, Joshua B, Kaplan MJ, Longaker MT, Weissman IL. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature. 466: 133-7. PMID 20596026 DOI: 10.1038/Nature09161  0.546
2006 Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR, Gudkov AV. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes & Development. 20: 236-52. PMID 16418486 DOI: 10.1101/Gad.1372606  0.563
2004 Lu T, Burdelya LG, Swiatkowski SM, Boiko AD, Howe PH, Stark GR, Gudkov AV. Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 101: 7112-7. PMID 15118089 DOI: 10.1073/Pnas.0402048101  0.551
2002 Zou X, Ray D, Aziyu A, Christov K, Boiko AD, Gudkov AV, Kiyokawa H. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Genes & Development. 16: 2923-34. PMID 12435633 DOI: 10.1101/Gad.1033002  0.556
1998 Axenovich SA, Kazarov AR, Boiko AD, Armin G, Roninson IB, Gudkov AV. Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: mapping of the domain associated with drug response. Cancer Research. 58: 3423-8. PMID 9699675  0.422
Show low-probability matches.